Document 3040 DOCN M94A3040 TI Viral phenotype and clinical outcome in HIV+ children. DT 9412 AU Munoz-Fernandez MA; Navarro J; Obregon E; Garcia D; Gurbindo D; Sampelayo T; Fernandez-Cruz E; Dept. Immunology, H. Gregorio Maranon, Madrid, Spain. SO Int Conf AIDS. 1994 Aug 7-12;10(1):167 (abstract no. PB0095). Unique Identifier : AIDSLINE ICA10/94369535 AB OBJECTIVE: To investigate whether highly replicative HIV-1 isolates in children has the ability to induce syncytium formation (SI) in PBMC and MT-2 cells, whereas slow/low viruses lack this capacity. METHODS: Sixty-four infants born of seropositive HIV mother were studied. Virus isolation was performed by cocultivation of the patient's PBMC cells with donor lymphocytes. Viral phenotype: PHA-stimulated PBMC were infected with cell-free supernatants from the virus cocultures (VC). After 7-10 days the infected PBMC were cultured with MT-2 cells and HIV were characterized for SI, and p24 Ag was quantified sequentially in VC supernatants. RESULTS: Only 14 out of 64 (22%) infants were positive by PCR and VC. HIV isolates were available in 13 out of 14 infected children. Of these 13 isolates, 6 were classified as rapid/high and 7 as slow/low virus. Highly replicative HIV isolates induced syncytia in PBMC and MT-2 cells, whereas slow/low virus did not. DISCUSSION AND CONCLUSIONS: Infants with rapid/high isolates will have a more rapid progressive course during the first months of life and higher levels of p24 antigenemia, while infants with slowly replicating HIV will do better. DE Giant Cells/MICROBIOLOGY Human HIV Core Protein p24/BLOOD HIV Seropositivity/CLASSIFICATION/*DIAGNOSIS/MICROBIOLOGY HIV-1/*PATHOGENICITY Infant Infant, Newborn Prognosis Slow Virus Diseases/CLASSIFICATION/DIAGNOSIS/MICROBIOLOGY Virulence Virus Replication/*PHYSIOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).